Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Genesis Molecular AI is seeking a PhD candidate to join as a research intern on generative modeling for molecular systems. You will collaborate with a world-class team to advance foundation models at scale, exploring diffusion, RL, and multi-modal learning.
You will work under a mentor, design experiments, and present findings. This is a hands-on role at the frontier of AI and biochemistry, with direct impact on drug discovery.
Join a world-class team at the forefront of AI and biochemistry.
At Genesis Molecular AI, we’re a tight-knit team of proven deep learning researchers, software engineers, and drug discovery pioneers. Our shared mission is nothing short of revolutionary: to forge the next generation of AI foundation models that will unlock groundbreaking therapies for patients with severe diseases.
We don’t just apply machine learning to biology; we are conducting fundamental research at the intersection of machine learning, physics, and computational chemistry, pushing the boundaries of each field. You will work side-by-side with top multidisciplinary researchers to design and build generative foundation models at scale, having access to ample compute and large-scale simulations.
This is an opportunity to operate as a full member of our research team and to drive forward our ML research agenda for generative modeling of molecular systems. You will be paired with a mentor to work on a high-impact research project at the frontier of generative AI. Your work will likely involve making advancements to novel foundation models, with potential projects in areas like diffusion models, large language models (LLMs), reinforcement learning (RL), and multi-modal learning. We’re looking for exceptional PhD candidates passionate about conducting novel research that contributes directly to our mission of discovering new medicines.
Genesis Molecular AI is pioneering foundation models for molecular AI to unlock a new era of drug design and development. Our generative and predictive AI platform, GEMS (Genesis Exploration of Molecular Space), integrates AI and physics into industry-leading models to generate and optimize drug molecules, including the breakthrough generative diffusion model Pearl for structure prediction. Genesis is backed by premier AI and life science investors, including a16z, NVIDIA, Rock Springs Capital, Menlo Ventures, T. Rowe Price, Fidelity, and Radical Ventures. Genesis has also signed category-leading AI-pharma deals, the most recent of which was a significant expansion with Incyte (see coverage in Forbes and GEN) with a total potential deal value of several billion dollars.
Genesis is headquartered in San Mateo, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.